Back

Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Drugs, devices, and multidisciplinary care in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Nina Nouhravesh

Duke Clinical Research Institute, Durham (United States of America)

5 More presentations in this session

Presentation thumbnail
Nationwide analysis of in-hospital mortality and renal infarction trends following cardiac output assist device placement from 2017 to 2020
Doctor A. Balaji (Brooklyn, US)
Abstract Slides
Presentation thumbnail
Beating the clock: the impact of heart failure duration on CRT efficacy
Mr E. Grama (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Optimizing aldosterone receptor antagonist therapy by sodium zirconium cyclosilicate in heart failure - OPRA-HF trial
Doctor C. Basic (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Understanding the benefits of renin-angiotensin-aldosterone system inhibitors and influence of hyperkalaemia on their prescription: a UK survey of healthcare professionals' views and practice
Doctor M. Wasef (Portsmouth, GB)
Abstract Slides Video
Presentation thumbnail
Echocardiographic evaluation of cardiac remodelling in a cohort of patients with heart failure and reduced ejection fraction treated with dapagliflozin
Doctor J. Bonini (Ferrara, IT)
Abstract Slides

Access the full session

Session thumbnail
Drugs, devices, and multidisciplinary care in heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources